It’s not often that commerical insurers get a pat on the back, but a recent Government Accounting Office study that compared home infusion coverage for Medicare beneficiaries and commerical insurers comes pretty close. Read more at: http://www.nxtbook.com/nxtbooks/medimedia/managedcare_201007/index.php?startid=8#/12/OnePage

Dosage and indication “creep” with the new biologics to treat inflammatory diseases have payers enforcing strict utilization policies. Physicians counter that payers can’t dictate treatment. With even more biologics on the horizon, and drug spend spiralling upward, both sides need…